Chief Executive Officer, H. Joseph Reiser, Ph.D. and Loraine V. Upham, COO proudly accept the 2009 North American Diabetes Mellitus Therapeutics Product of the Year Award on behalf of CureDM, from Art Robbins, President of Frost & Sullivan North America. The award which recognizes the development of Pancreate™ was presented at the Frost & Sullivan HealthCare Innovation Awards Banquet held in San Antonio, Texas on November 19, 2009.